1. Terson A. De l’hémorrhagie dans le corps vitre au cours de l'hémorrhagie cerebrale. Clin Ophthalmol. 1990; 6:309–312.
2. Sakamoto M, Nakamura K, Shibata M, Yokoyama K, Matsuki M, Ikeda T. Magnetic resonance imaging findings of Terson’s syndrome suggesting a possible vitreous hemorrhage mechanism. Jpn J Ophthalmol. 2010; 54:135–139.
Article
3. Stienen MN, Lücke S, Gautschi OP, Harders A. Terson haemorrhage in patients suffering aneurysmal subarachnoid haemorrhage: a prospective analysis of 60 consecutive patients. Clin Neurol Neurosurg. 2012; 114:535–538.
Article
4. Swallow CE, Tsuruda JS, Digre KB, Glaser MJ, Davidson HC, Harnsberger HR. Terson syndrome: CT evaluation in 12 patients. AJNR Am J Neuroradiol. 1998; 19:743–747.
5. Gralla J, Brekenfeld C, Mordasini P, Schroth G. Mechanical Thrombolysis and Stenting in Acute Ischemic Stroke. Stroke. 2012; 43:280–285.
Article
6. Rha JH, Saver JL. The impact of recanalization on ischemic stroke outcome: a meta-analysis. Stroke. 2007; 38:967–973.
7. Shi ZS, Liebeskind DS, Loh Y, Saver JL, Starkman S, Vespa PM, et al. Predictors of subarachnoid hemorrhage in acute ischemic stroke with endovascular therapy. Stroke. 2010; 41:2775–2781.
Article
8. Yoon W, Jung MY, Jung SH, Park MS, Kim JT, Kang HK. Subarachnoid hemorrhage in a multimodal approach heavily weighted toward mechanical thrombectomy with solitaire stent in acute stroke. Stroke. 2013; 44:414–419.
Article
9. Superstein R, Gomolin JE, Hammouda W, Rosenberg A, Overbury O, Arsenault C. Prevalence of ocular hemorrhage in patients receiving warfarin therapy. Can J Ophthalmol. 2000; 35:385–389.
Article
10. Manschot WA. Subarachnoid hemorrhage: intraocular symptoms and their pathogenesis. Am J Ophthalmol. 1954; 38:501–505.
11. Fahmy JA. Fundal haemorrhages in ruptured intracranial aneurysms. II. Correlation with the clinical course. Acta Ophthalmol (Copenh). 1973; 51:299–304.
Article
12. McCarron MO, Alberts MJ, McCarron P. A systematic review of Terson\'s syndrome: frequency and prognosis after subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry. 2004; 75:491–493.
Article
13. Ogawa T, Kitaoka T, Dake Y, Amemiya T. Terson syndrome: a case report suggesting the mechanism of vitreous hemorrhage. Ophthalmology. 2001; 108:1654–1656.
14. Sand KM, Midelfart A, Thomassen L, Melms A, Wilhelm H, Hoff JM. Visual impairment in stroke patients--a review. Acta Neurol Scand Suppl. 2013; 196:52–56.
15. Khan S, Leung E, Jay WM. Stroke and visual rehabilitation. Top Stroke Rehabil. 2008; 15:27–36.
Article
16. Berry C, Weir C, Hammer H. A case of intraocular haemorrhage secondary to thrombolytic therapy. Acta Ophthalmol Scand. 2002; 80:561–562.
Article
17. Chorich L, Derick R, Chambers R, Cahill KV, Quartetti EJ, Fry JA, Bush CA. Hemorrhagic ocular complications associated with the use of systemic thrombolytic agents. Ophthalmology. 1998; 105:428–431.
Article
18. Kaba RA, Cox D, Lewis A, Bloom P, Dubrey S. Intraocular haemorrhage after thrombolysis. Lancet. 2005; 365:330.
Article
19. Hormese M, Wichter M. Vitreo-retinal hemorrhage after thrombolysis in a patient with acute ischemic stroke: a case report. Front Neurol. 2012; 3:71.
Article